CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | ROBINS CHAD M CEO and Chairman | Sale | −5,000 | $46.45 | $232K | 1,738,680 |
| 2020-09-16 | ROBINS CHAD M CEO and Chairman | Sale | −5,100 | $47.46 | $242K | 1,778,580 |
| 2020-09-16 | ROBINS CHAD M CEO and Chairman | Sale | −400 | $48.26 | $19K | 1,778,180 |
| 2020-09-16 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −16,680 | 228,000 | ||
| 2020-09-15 | HERSHBERG ROBERT Director | Option exercise | +2,000 | $0.45 | $900 | 2,000 |
| 2020-09-15 | HERSHBERG ROBERT Director | Sale | −2,000 | $42.58 | $85K | 0 |
| 2020-09-15 | HERSHBERG ROBERT Director | Option exercise · Stock Option (Right to Buy) | −2,000 | 65,000 | ||
| 2020-09-15 | SANG CHARLES SVP, External Affairs | Option exercise | +25,000 | $6.32 | $158K | 25,000 |
| 2020-09-15 | SANG CHARLES SVP, External Affairs | Sale | −25,000 | $44.00 | $1.1M | 0 |
| 2020-09-15 | SANG CHARLES SVP, External Affairs | Option exercise · Stock Option (Right to Buy) | −25,000 | 55,000 | ||
| 2020-09-15 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 2,000 |
| 2020-09-15 | LO FRANCIS Chief People Officer | Sale | −2,000 | $42.58 | $85K | 0 |
| 2020-09-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 192,000 | ||
| 2020-09-14 | SANG CHARLES SVP, External Affairs | Option exercise | +25,000 | $6.55 | $164K | 25,000 |
| 2020-09-14 | SANG CHARLES SVP, External Affairs | Sale | −25,000 | $42.50 | $1.1M | 0 |
| 2020-09-14 | SANG CHARLES SVP, External Affairs | Option exercise · Stock Option (Right to Buy) | −25,000 | 205,000 | ||
| 2020-09-11 | BALDO LANCE Chief Medical Officer | Option exercise | +4,149 | $7.80 | $32K | 4,149 |
| 2020-09-11 | BALDO LANCE Chief Medical Officer | Sale | −4,149 | $40.00 | $166K | 0 |
| 2020-09-11 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,149 | 425,000 | ||
| 2020-09-11 | Cohen Chad M Chief Financial Officer | Option exercise | +8,588 | $6.32 | $54K | 9,588 |
Page 91 of 120 · 2,386 trades